Literature DB >> 22914929

Terminal differentiation of human epidermal stem cells on micro-patterned substrates.

John T Connelly1.   

Abstract

Extracellular signals play a central role in coordinating the growth and differentiation of epidermal stem cells. This protocol describes a technique for quantitatively examining the influence of extracellular matrix (ECM) interactions on keratinocyte terminal differentiation through the use of micro-patterned, polymer substrates. Circular islands of type I collagen are created, first by micro-contact printing and surface-initiated polymerization of a protein resistant background. The unprotected gold is then coated with collagen by passive adsorption. When human keratinocytes are seeded onto these substrates, limited adhesion on the smallest islands induces terminal differentiation, characterized by increased involucrin, transglutaminase, and periplakin expression, as well as reduced proliferation. This platform provides a robust assay for studying the terminal differentiation of human epidermal stem cells and the regulatory roles of specific cell-matrix interactions in this process.

Entities:  

Mesh:

Year:  2012        PMID: 22914929     DOI: 10.1007/978-1-61779-980-8_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  Micro-scaled topographies direct differentiation of human epidermal stem cells.

Authors:  Sebastiaan Zijl; Aliaksei S Vasilevich; Priyalakshmi Viswanathan; Ayelen Luna Helling; Nick R M Beijer; Gernot Walko; Ciro Chiappini; Jan de Boer; Fiona M Watt
Journal:  Acta Biomater       Date:  2018-12-05       Impact factor: 8.947

2.  Phlorizin, an Active Ingredient of Eleutherococcus senticosus, Increases Proliferative Potential of Keratinocytes with Inhibition of MiR135b and Increased Expression of Type IV Collagen.

Authors:  Hye-Ryung Choi; Kyung-Mi Nam; Hyun-Sun Lee; Seung-Hye Yang; Young-Soo Kim; Jongsung Lee; Akira Date; Kazumi Toyama; Kyoung-Chan Park
Journal:  Oxid Med Cell Longev       Date:  2016-03-06       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.